Educational Intervention for Financial Burden in Gynecologic Cancers
(PCOC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help patients manage the costs associated with gynecologic cancer treatment. It tests an educational program called Proactive Costs of Care, a one-time, 30-minute session guiding patients on handling treatment expenses. The researchers aim to determine if this program can be effectively delivered and if it boosts confidence while reducing financial stress. This trial might suit someone diagnosed with gynecologic cancer, currently undergoing treatment at Cedars-Sinai Medical Center, and able to communicate in English. Participants will attend the educational session and complete two surveys to share their experiences. As an unphased trial, this study offers a unique opportunity to contribute to research that could ease financial burdens for future patients.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. It focuses on an educational session about managing the costs of cancer care.
What prior data suggests that this educational intervention is safe for patients with gynecologic cancers?
Research on the Proactive Costs of Care program is ongoing. So far, no published safety information or reports of problems exist for this specific program. This educational program aims to help patients manage cancer care costs and includes a one-time session with a guide and a cost tracker. Although documented safety data is not yet available, educational programs like this typically carry low risk because they do not involve medications or medical procedures. Participants will engage in discussions and complete surveys, which are generally easy and safe activities.12345
Why are researchers excited about this trial?
Researchers are excited about the Proactive Costs of Care Intervention because it addresses the financial burden faced by patients with gynecologic cancers, which is an aspect often overlooked in current treatment options. While standard treatments focus on medical and therapeutic approaches, this intervention is unique as it proactively educates patients about the costs associated with their care. By empowering patients with financial information and planning strategies, it aims to alleviate stress and improve overall well-being, potentially leading to better health outcomes. This innovative approach could pave the way for integrating financial education into cancer care, offering a more holistic treatment experience.
What evidence suggests that this educational intervention is effective for reducing financial distress in gynecologic cancer patients?
Research has shown that the costs of gynecologic cancer care can be very high and stressful. For example, the average yearly cost for ovarian cancer care exceeds $200,000. This financial stress can add to the emotional distress patients experience. In this trial, participants will receive the Proactive Costs of Care program, designed to help patients manage these expenses better. By teaching patients how to handle costs, this program may increase their confidence and reduce financial worries. Although specific data on the program's effectiveness is limited, focusing on financial education appears to be a promising way to ease financial burdens.678910
Who Is on the Research Team?
Margaret Liang, MD, MS
Principal Investigator
Cedars-Sinai Medical Center
Are You a Good Fit for This Trial?
This trial is for patients with gynecologic cancers who are starting new treatments and facing financial hardship. It's designed to help them manage the costs of cancer care. Participants must be willing to complete a 30-minute session and two surveys, one before and another three months after the intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants complete the Proactive Costs of Care intervention, a one-time 30-minute session with a lay educator
Follow-up
Participants complete a follow-up survey to assess changes in financial distress and self-efficacy
What Are the Treatments Tested in This Trial?
Interventions
- Proactive Costs of Care Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
Merck Sharp & Dohme LLC
Industry Sponsor
Chirfi Guindo
Merck Sharp & Dohme LLC
Chief Marketing Officer since 2022
Degree in Engineering from Ecole Centrale de Paris, MBA from New York University Stern School of Business
Robert M. Davis
Merck Sharp & Dohme LLC
Chief Executive Officer since 2021
JD from Northwestern University Pritzker School of Law, MBA from Northwestern University Kellogg Graduate School of Management, Bachelor's in Finance from Miami University